期刊文献+

盐酸羟考酮缓释片用于疼痛治疗致谵妄嗜睡的药学监护 被引量:10

Pharmaceutical Care for A Patient with Delirium and Drowsiness Induced by Oxycodone Hydrochloride Prolonged-release Tablet During the Cancer Pain Treatment
下载PDF
导出
摘要 目的探讨临床药师参与癌痛患者药物治疗的实践方法。方法临床药师参与1例癌痛患者的镇痛治疗,患者使用盐酸羟考酮缓释片联合盐酸吗啡片进行剂量滴定,治疗中出现谵妄、嗜睡反应。药师分析了患者出现谵妄、嗜睡的可能原因,并建议医师合理地调整治疗方案。结果临床药师的建议部分被采纳,经降低羟考酮缓释片剂量、将羟考酮更换成芬太尼透皮贴剂后患者谵妄、嗜睡逐渐消失,疼痛得到较好控制。结论在临床实践中,尤其在面临少见的药物不良反应时,临床药师通过个体化药物治疗,有助于保证患者用药安全、有效。 Objective To discuss the pharmaceutical care protocol and methods for clinical pharmacists taking part in cancer pain management. Methods A patient developed delirium and drowsiness after using oxycodone hydrochloride prolonged-release tablet( OXYCONTIN) and morphine hydrochloride tablet for pain titration treatment. The clinical pharmacist analyzed the reasons of delirium and drowsiness,and suggested a dose reduction of OXYCONTIN or converting OXYCONTIN to another opioid analgesic. Results The suggestion of the clinical pharmacist was partly accepted. After adjusting the treatment,the delirium and drowsiness disappeared gradually,and the pain was well controlled. Conclusion In clinical practice,especially when faced with a rare adverse drug reaction,clinical pharmacists are helpful for ensuring the safety and effectiveness in pain management,as well as improving the level of the treatment,by the implementation of individualized drug therapy.
作者 刘金梅 蔡晶
出处 《医药导报》 CAS 2017年第1期96-98,共3页 Herald of Medicine
关键词 羟考酮缓释片 临床药师 癌痛 谵妄 嗜睡 Oxycodone hydrochloride prolonged-release tablet Clinical pharmacist Cancer pain Delirium Drowsiness
  • 相关文献

参考文献10

二级参考文献128

  • 1张晓娟,晋建华,刘建中,李思进,李险峰,张承刚,郭睿,宁艳丽.153Sm-乙二胺四甲基撑膦酸治疗恶性肿瘤骨转移疼痛[J].肿瘤研究与临床,2008,20(3):182-184. 被引量:2
  • 2刘庆涛,金红梅.大剂量美施康定治疗癌性疼痛1例体会[J].肿瘤研究与临床,2004,16(4):271-272. 被引量:3
  • 3孙新宇,高之旭,冯锋,温全球,冯少慧,盛建华,陈建,苗国栋,于欣.氟哌啶醇与利培酮治疗痴呆患者精神行为症状的随机双盲对照研究[J].中华精神科杂志,2004,37(3):156-159. 被引量:54
  • 4沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215. 被引量:255
  • 5Siverman RB. From basic acience to blockbuster drugs, the dis- covery of lyrica[J]. Angew Chem Int Ed, 2008,47 (19) : 3500- 3504. 被引量:1
  • 6Dooley DJ, Taylor CP, Donevan S, et al. Ca2 + channel al- pha2delta ligands: novel modulators of neurotransmission[J]. Trends Pharmacol Sci , 2007,28 : 75-82,. 被引量:1
  • 7Pfizer. corn [homepage on the Internet]. Pfizer, Inc. ; c2002 -2009 [updated 2009 Dec]. Available from: http://www, pfi- zer. com/files/products/uspi_ lyriea, pdf Accessed Mar 10, 2010. 被引量:1
  • 8US Prescribing Information for Lyrica (Pfizer) Available from: http://www, lyrica, com/. 2009,Accessed Dec 9, 2009. 被引量:1
  • 9Shneker BF, McAuley JW. Pregabalin: A New Neuromodula- tor with Broad Therapeutic Indications. Annals Pharmacother, 2005,39 :2029-2037. 被引量:1
  • 10Satoh J, Yagihashi S, Baba M,etal. Efficacy and safety of pre- gabalin for treating neuropathic pain associated with diabetic peripheral neuropathy:, a 14 week, randomized, double-blind, placebo-controlled trial[J]. Diabet Med,2011,28(1)..109-116. 被引量:1

共引文献179

同被引文献87

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部